Impact of COVID-19 on in vivo work and patient sample availability for cancer research.
Where this comes from
- Record sourced from PubMed, PMID 33462500.
- Also identified by DOI 10.1038/s41568-021-00333-5 and PMC identifier 7812559.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The COVID-19 pandemic has destabilized the traditional bench to bedside workflow of cancer research. Particularly, in vivo experimentation plus the collection and distribution of patient samples has been significantly affected. Strategies are needed now to revolutionize current cancer research practices in order to avoid history repeating itself in future pandemics.
Medical subject headings
- Biomedical Research
- COVID-19
- Neoplasms